Ryan Savitz
EVP, CFO & CBO · Dianthus Therapeutics, Inc. /DE/
- 2025
- Jul 13, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ryan Savitz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marino Garcia - $27.96M in DNTH purchases and sales in the last 12 months
- Simrat Randhawa - $15.00M in DNTH purchases and sales in the last 12 months
- Edward Carr - $5.59M in DNTH purchases and sales in the last 12 months
- Adam M. Veness - $4.63M in DNTH purchases and sales in the last 12 months
- Paula Soteropoulos - $2.25M in DNTH purchases and sales in the last 12 months
- Anne McGeorge - $845K in DNTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ryan Savitz?
Ryan Savitz is a corporate insider, tracked as EVP, CFO & CBO of Dianthus Therapeutics, Inc. /DE/ (DNTH). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ryan Savitz last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 7 filings going back to 2025.
Has Ryan Savitz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($14.99M) across all tracked filings.
